125 related articles for article (PubMed ID: 11277031)
1. Internet eases negotiations for FDA, drug firms.
Goedert J
Health Data Manag; 2001 Mar; 9(3):14-5. PubMed ID: 11277031
[No Abstract] [Full Text] [Related]
2. The brave new world of healthcare e-commerce.
Hirsch R
J Cardiovasc Manag; 1999; 10(3):13-4. PubMed ID: 10557912
[No Abstract] [Full Text] [Related]
3. FDA warns about fraudulent STD treatments.
AIDS Patient Care STDS; 2008 Apr; 22(4):353. PubMed ID: 18434953
[No Abstract] [Full Text] [Related]
4. Outsourcing challenges FDA to strengthen oversight abroad.
Torres C
Nat Med; 2010 Feb; 16(2):139. PubMed ID: 20134448
[No Abstract] [Full Text] [Related]
5. Steve Carney talks to Vincent Lee on the pharma industry, the FDA and public education with respect to drugs and their development.
Lee VH
Drug Discov Today; 2005 Nov; 10(21):1411-4. PubMed ID: 16243258
[No Abstract] [Full Text] [Related]
6. FDA and EMEA pool scientific advice.
Katsnelson A
Nat Biotechnol; 2004 Dec; 22(12):1490-1. PubMed ID: 15583642
[No Abstract] [Full Text] [Related]
7. FDA takes action against firms in scandal over generic products.
Pollner F
Med World News; 1989 Sep; 30(17):14-5. PubMed ID: 10294736
[No Abstract] [Full Text] [Related]
8. FDA notifications. Gilead issues letter about virologic failure.
AIDS Alert; 2003 Dec; 18(12):159-60. PubMed ID: 14696542
[No Abstract] [Full Text] [Related]
9. FDA regulation of clinical software: what does this mean for the industry?
Trimbach J
Healthc Inform; 1995 Nov; 12(11):10, 12, 14. PubMed ID: 10152714
[No Abstract] [Full Text] [Related]
10. New FDA guidance on electronic records and signatures.
Donawa M
Med Device Technol; 2001 Nov; 12(9):32-5. PubMed ID: 12938536
[TBL] [Abstract][Full Text] [Related]
11. FDA allows drug firms to distribute journal articles about unapproved uses.
Tanne JH
BMJ; 2009 Jan; 338():b187. PubMed ID: 19153126
[No Abstract] [Full Text] [Related]
12. FDA bans firms from importing and distributing contaminated animal drugs.
J Am Vet Med Assoc; 1999 May; 214(10):1459. PubMed ID: 10340065
[No Abstract] [Full Text] [Related]
13. Protecting your domain.
Eagle TE
Mich Health Hosp; 2002; 38(1):24-6. PubMed ID: 11828575
[TBL] [Abstract][Full Text] [Related]
14. The promise and peril of direct-to-consumer prescription drug promotion on the Internet.
Hall TS
DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476
[No Abstract] [Full Text] [Related]
15. How should FDA regulate prescription drug promotion on the Internet?
Opderbeck DW
Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
[TBL] [Abstract][Full Text] [Related]
16. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
Patsner B
Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
[No Abstract] [Full Text] [Related]
17. Regulated firms: a statistical profile.
Hecht A
FDA Consum; 1977 Apr; 11(3):24. PubMed ID: 10304990
[No Abstract] [Full Text] [Related]
18. Drug marketing and the new media.
Webb S
Nat Biotechnol; 2010 May; 28(5):396-8. PubMed ID: 20458296
[No Abstract] [Full Text] [Related]
19. Public policy implications of cross-border Internet pharmacies.
Cohen JC
Manag Care; 2004 Mar; 13(3 Suppl):14-6. PubMed ID: 15074164
[No Abstract] [Full Text] [Related]
20. FDA debuts drug product catalog.
AIDS Patient Care STDS; 2003 Jul; 17(7):370. PubMed ID: 14658441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
